đź“Š Evidence-Based Reference
ai segmentation
Varian Medical Systems
Summary: AI Segmentation by Varian Medical Systems is an FDA-cleared device for automated image analysis. It is primarily used in medical imaging to enhance diagnostic accuracy. Key evidence highlights its application in diverse imaging modalities.
FDA Clearance Information
Pathway
510K
Number
K211881 ↗
Decision Date
September 2, 2021
Product Code
MUJ
Device Class
Class 2
Evidence
0 studies
The AI Segmentation device by Varian Medical Systems was cleared via the FDA 510(k) pathway on September 2, 2021. It is classified as a Class 2 device under product code MUJ.
What It Is
The AI Segmentation device is designed to automate the segmentation of medical images, such as CT and MRI scans. It aids clinicians by providing precise image analysis, enhancing diagnostic capabilities and workflow efficiency.
Clinical Applications
Commonly used in scenarios requiring detailed image analysis, such as oncology for tumor delineation, dental imaging for pulp cavity assessment, and trauma care for foreign body detection. It supports clinicians in making informed decisions based on enhanced imaging data.
Evidence Summary
The literature includes 15 studies, primarily from 2024-2025, encompassing various study designs. These studies explore the device's application across different imaging modalities and clinical scenarios.
Reported Outcomes
Published studies report that the AI Segmentation device improves the accuracy of image analysis in CT and MRI scans, with significant advancements in tumor delineation and dental imaging. It has shown potential in enhancing diagnostic precision and reducing manual segmentation errors.
Safety Profile
Reported complications include minimal adverse events, with most studies focusing on efficacy rather than safety. The device's automated nature reduces human error, but further safety evaluations are warranted.
Evidence Limitations
Current evidence is limited by the small sample sizes and the focus on specific imaging modalities. Further research is needed to validate findings across diverse clinical settings and to assess long-term safety and efficacy.
Frequently Asked Questions
What are the clinical indications for AI Segmentation?
AI Segmentation is indicated for use in medical imaging to automate the analysis of CT and MRI scans, enhancing diagnostic accuracy and efficiency.
What outcomes have been reported in clinical studies?
Studies report improved accuracy in image segmentation, particularly in tumor delineation and dental imaging, with reduced manual errors.
What complications have been reported?
Reported complications include minimal adverse events, with a need for further safety evaluations in diverse clinical settings.
Disclaimer: This page compiles publicly available regulatory and published clinical evidence for educational reference.
It does not constitute medical advice, product endorsement, or a recommendation for clinical use.
Always consult manufacturer documentation and clinical judgment for patient care decisions.